2025-524256-64-00Not yet recruitingPhase 4
The impact of extra-fine inhalation corticosteroid particles on small-airway disease in Chronic Obstructive Pulmonary Disease (COPD): a randomized, prospective cross-over trial.
Source: EU CTIS (euclinicaltrials.eu) · Last updated 19 Jan 2026
- Status (registry)
- Not yet recruiting
- Phase (registry)
- Phase 4
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- First submitted
- 15 Oct 2025
- Start date
- 1 Dec 2025
- Lead sponsor
- CHU Saint Pierre
- Diseases
- COPD
- EU CT number
- 2025-524256-64-00
What you commit to
- Study type: Interventional · Phase 4
- Planned participants: 60
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| CHU Saint-Pierre | Brussels | Belgium | Not yet recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.